| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.22 | 8e-05 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0005 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0009 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.002 |